5-amino-1mq fda approval status Peptide 5-Amino-1MQ
Description
Safe profile: Clinical trials show AOD-9604 is well tolerated with a side-effect rate similar to placebo
In some cases, healthcare providers may adjust the frequency, for example, some patients might be advised to take the injection twice weekly or once every two weeks, depending on their specific goals and how they respond to treatment
Neelakantan H, et al
Since he seemed initially to benefit from this treatment, it is still possible that he was deficient
